ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Abstract PR13: Clinical safety and activity from a phase 1 study of LOXO-101, a selective TRKA/B/C inhibitor, in solid-tumor patients with NTRK gene fusions
Mapping Intimacies
◽
10.1158/1535-7163.targ-15-pr13
◽
2015
◽
Cited By ~ 6
Author(s):
David S. Hong
◽
Marcia S. Brose
◽
Robert C. Doebele
◽
Alice T. Shaw
◽
Afshin Dowlati
◽
...
Keyword(s):
Solid Tumor
◽
Phase 1
◽
Gene Fusions
◽
Tumor Patients
◽
Phase 1 Study
◽
Clinical Safety
Download Full-text
Related Documents
Cited By
References
150O Clinical safety and activity from a phase 1 study of LOXO-101, a selective TRKA/B/C inhibitor, in solid-tumor patients with NTRK gene fusions
Annals of Oncology
◽
10.1093/annonc/mdw579.002
◽
2016
◽
Vol 27
(suppl_9)
◽
Cited By ~ 1
Author(s):
D.S. Hong
◽
A. Dowlati
◽
H.A. Burris
◽
J.J. Lee
◽
M.S. Brose
◽
...
Keyword(s):
Solid Tumor
◽
Phase 1
◽
Gene Fusions
◽
Tumor Patients
◽
Phase 1 Study
◽
Clinical Safety
Download Full-text
150O Clinical safety and activity from a phase 1 study of LOXO-101, a selective TRKA/B/C inhibitor, in solid-tumor patients with NTRK gene fusions
Annals of Oncology
◽
10.1016/s0923-7534(21)00308-2
◽
2016
◽
Vol 27
◽
pp. ix46
Author(s):
D.S. Hong
◽
A. Dowlati
◽
H.A. Burris
◽
J.J. Lee
◽
M.S. Brose
◽
...
Keyword(s):
Solid Tumor
◽
Phase 1
◽
Gene Fusions
◽
Tumor Patients
◽
Phase 1 Study
◽
Clinical Safety
Download Full-text
Clinical safety and activity from a phase 1 study of LOXO-101, a selective TRKA/B/C inhibitor, in solid-tumor patients with NTRK gene fusions
European Journal of Cancer
◽
10.1016/s0959-8049(17)30561-0
◽
2017
◽
Vol 72
◽
pp. S148
◽
Cited By ~ 6
Author(s):
D.S. Hong
◽
A. Dowlati
◽
H.A. Burris
◽
J.J. Lee
◽
M.S. Brose
◽
...
Keyword(s):
Solid Tumor
◽
Phase 1
◽
Gene Fusions
◽
Tumor Patients
◽
Phase 1 Study
◽
Clinical Safety
Download Full-text
Phase 1 study of capmatinib in MET‐positive solid tumor patients: Dose escalation and expansion of selected cohorts
Cancer Science
◽
10.1111/cas.14254
◽
2019
◽
Vol 111
(2)
◽
pp. 536-547
◽
Cited By ~ 4
Author(s):
Yung‐Jue Bang
◽
Wu‐Chou Su
◽
Martin Schuler
◽
Do‐Hyun Nam
◽
Wan Teck Lim
◽
...
Keyword(s):
Dose Escalation
◽
Solid Tumor
◽
Phase 1
◽
Tumor Patients
◽
Phase 1 Study
Download Full-text
Abstract CT008: Clinical safety and activity from a phase I study of LOXO-101, a selective TRKA/B/C inhibitor, in solid-tumor patients with NTRK gene fusions
10.1158/1538-7445.am2016-ct008
◽
2016
◽
Cited By ~ 6
Author(s):
David S. Hong
◽
Anna F. Farago
◽
Marcia S. Brose
◽
Howard A. Burris
◽
Afshin Dowlati
◽
...
Keyword(s):
Phase I
◽
Solid Tumor
◽
Phase I Study
◽
Gene Fusions
◽
Tumor Patients
◽
Clinical Safety
Download Full-text
Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients
Cancer Medicine
◽
10.1002/cam4.491
◽
2015
◽
Vol 4
(10)
◽
pp. 1472-1483
◽
Cited By ~ 30
Author(s):
Talia Golan
◽
Tal Grenader
◽
Patricia Ohana
◽
Yasmine Amitay
◽
Hilary Shmeeda
◽
...
Keyword(s):
Mitomycin C
◽
Solid Tumor
◽
Phase 1
◽
Advanced Solid Tumor
◽
Tumor Patients
◽
Phase 1 Study
Download Full-text
Abstract B13: Biomarker Analyses from Dose Escalation Phase of FASN Inhibitor TVB-2640 Phase 1 Study Shows Target Engagement in Solid Tumor Patients
10.1158/1535-7163.targ-15-b13
◽
2015
◽
Author(s):
Marie O'Farrell
◽
Richard Crowley
◽
Timothy Heuer
◽
Marina Fridlib
◽
Doug Buckley
◽
...
Keyword(s):
Dose Escalation
◽
Solid Tumor
◽
Phase 1
◽
Target Engagement
◽
Tumor Patients
◽
Phase 1 Study
Download Full-text
Abstract 2675: Biomarker and PK/PD analyses of first in class FASN inhibitor TVB-2640 in a first-in-human phase 1 study in solid tumor patients
10.1158/1538-7445.am2015-2675
◽
2015
◽
Cited By ~ 2
Author(s):
Marie O'Farrell
◽
Richard Crowley
◽
Timothy S. Heuer
◽
Doug Buckley
◽
Chris M. Rubino
◽
...
Keyword(s):
Solid Tumor
◽
Phase 1
◽
Tumor Patients
◽
Phase 1 Study
Download Full-text
Abstract 5337: Phase 1 study of bavituximab in advanced solid tumor malignancies: Final results
10.1158/1538-7445.am10-5337
◽
2010
◽
Cited By ~ 1
Author(s):
Nuhad Ibrahim
◽
Lucas Wong
◽
Alison Stopeck
◽
Lee S. Rosen
◽
David E. Gerber
◽
...
Keyword(s):
Solid Tumor
◽
Phase 1
◽
Advanced Solid Tumor
◽
Phase 1 Study
Download Full-text
Phase 1 and Pharmacokinetic Study of Intravenous Irinotecan in Refractory Solid Tumor Patients with Hepatic Dysfunction
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-05-2152
◽
2006
◽
Vol 12
(12)
◽
pp. 3782-3791
◽
Cited By ~ 22
Author(s):
Larry J. Schaaf
◽
Lisa A. Hammond
◽
Stuart J. Tipping
◽
Richard M. Goldberg
◽
Rakesh Goel
◽
...
Keyword(s):
Pharmacokinetic Study
◽
Solid Tumor
◽
Hepatic Dysfunction
◽
Phase 1
◽
Tumor Patients
◽
Refractory Solid Tumor
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close